Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine in Bipolar I Depression
NCT00510146Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of olanzapine in bipolar I disorder, sponsored by Eli Lilly and Company. Started Aug 2007; status: completed.
02
Drugs
olanzapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00510146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510146.